| 000 | 01602 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513130300.0 | ||
| 264 | 0 | _c19971114 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0014-2980 | ||
| 024 | 7 |
_a10.1002/eji.1830270929 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSewell, A K | |
| 245 | 0 | 0 |
_aAntagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _cSep 1997 |
||
| 300 |
_a2323-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
| 650 | 0 | 4 | _aClonal Anergy |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 |
_aGene Products, gag _ximmunology |
| 650 | 0 | 4 |
_aHIV Antigens _ximmunology |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aPeptides _ximmunology |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aViral Proteins |
| 650 | 0 | 4 | _agag Gene Products, Human Immunodeficiency Virus |
| 700 | 1 | _aHarcourt, G C | |
| 700 | 1 | _aGoulder, P J | |
| 700 | 1 | _aPrice, D A | |
| 700 | 1 | _aPhillips, R E | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 27 _gno. 9 _gp. 2323-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.1830270929 _zAvailable from publisher's website |
| 999 |
_c9313139 _d9313139 |
||